TY - JOUR
T1 - Personalized respiratory medicine
T2 - Exploring the horizon, addressing the issues: Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014
AU - Agustí, Alvar
AU - Antó, Josep Maria
AU - Auffray, Charles
AU - Barbé, Ferran
AU - Barreiro, Esther
AU - Dorca, Jordi
AU - Escarrabill, Joan
AU - Faner, Rosa
AU - Furlong, Laura I.
AU - Garcia-Aymerich, Judith
AU - Gea, Joaquim
AU - Lindmark, Bertil
AU - Monsó, Eduard
AU - Plaza, Vicente
AU - Puhan, Milo A.
AU - Roca, Josep
AU - Ruiz-Manzano, Juan
AU - Sampietro-Colom, Laura
AU - Sanz, Ferran
AU - Serrano, Luis
AU - Sharpe, James
AU - Sibila, Oriol
AU - Silverman, Edwin K.
AU - Sterk, Peter J.
AU - Sznajder, Jacob I.
PY - 2015/2/15
Y1 - 2015/2/15
N2 - This Pulmonary Perspective summarizes the content and main conclusions of an international workshop on personalized respiratory medicine coorganized by the Barcelona Respiratory Network (www.brn.cat) and the AJRCCM in June 2014. It discusses (1) its definition and historical, social, legal, and ethical aspects; (2) the view from different disciplines, including basic science, epidemiology, bioinformatics, and network/systems medicine; (3) the bottlenecks and opportunities identified by some currently ongoing projects; and (4) the implications for the individual, the healthcare system and the pharmaceutical industry. The authors hope that, although it is not a systematic review on the subject, this document can be a useful reference for researchers, clinicians, healthcare managers, policy-makers, and industry parties interested in personalized respiratory medicine.
AB - This Pulmonary Perspective summarizes the content and main conclusions of an international workshop on personalized respiratory medicine coorganized by the Barcelona Respiratory Network (www.brn.cat) and the AJRCCM in June 2014. It discusses (1) its definition and historical, social, legal, and ethical aspects; (2) the view from different disciplines, including basic science, epidemiology, bioinformatics, and network/systems medicine; (3) the bottlenecks and opportunities identified by some currently ongoing projects; and (4) the implications for the individual, the healthcare system and the pharmaceutical industry. The authors hope that, although it is not a systematic review on the subject, this document can be a useful reference for researchers, clinicians, healthcare managers, policy-makers, and industry parties interested in personalized respiratory medicine.
UR - http://www.scopus.com/inward/record.url?scp=84922895251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922895251&partnerID=8YFLogxK
U2 - 10.1164/rccm.201410-1935PP
DO - 10.1164/rccm.201410-1935PP
M3 - Article
C2 - 25531178
AN - SCOPUS:84922895251
SN - 1073-449X
VL - 191
SP - 391
EP - 401
JO - American Review of Respiratory Disease
JF - American Review of Respiratory Disease
IS - 4
ER -